Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Innovent Announces Global Collaboration with Hutchison MediPharma to Evaluate Combination of Sintilimab and Fruquintinib in Solid Tumors 2018-11-30 08:00
NMPA Accepts Biosimilar New Drug Application for IBI303, a Biosimilar Candidate to Humira(R) (adalimumab) 2018-11-13 08:00
Innovent Presents Clinical Data of Anti-PD-1 Antibody Sintilimab in Patients with First-line Squamous NSCLC at Asia Conference on Lung Cancer 2018 2018-11-09 15:18
1 14 15 16 17 18